FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995232559> ?p ?o ?g. }

• W1995232559 endingPage "354" @default.
• W1995232559 startingPage "339" @default.
• W1995232559 abstract "Although the overview above provides a partial molecular picture of the early stages of stepwise hepatocarcinogenesis. it should be emphasized that tumor and nontumor liver contain multiple changes, and that there is variability in their profile among different patients even within single studies. Variability in the number and types of genetic changes has also been observed geographically, and may be dependent upon the etiology of the tumor (viral, chemical or both). Interestingly, HBxAg inactivates tumor suppressors (such as p53 [by direct binding] and Rb [by stimulating its phosphorylation]) early in carcinogenesis that are mutated later during tumor progression. HBxAg also constitutively activates signal transduction pathways, such as those involving c-jun and ras, and activates oncogenes,such as c-nloc, that are otherwise activated by 3-catenin mutations. These findings suggest common molecular targets in hepatocarcinogenesis, despite different mechanisms of activation or inactivation. These observations need to be exploited in future drug discovery and in the development of new therapeutics. Heterogeneity in the mechanisms of tumor development, evidenced by the differences in the up- and down regulated genes reported in micro array analyses, as well as in the genetic loci that undergo mutation or LOH indifferent reports, has now been well documented. This suggests that there are multiple pathways to HCC, and that there is redundancy in the pathways that regulate cell growth and survival. These findings also reflect that,although hepatocarcinogenesis is multistep, the molecular changes that underpin histopathological changes in tumor development are likely to be different or only partially overlapping in individual tumors. Overall, the consequences of these changes suggest that the pathogenesis of HCC is accompanied by a progressive loss of differentiation, loss of normal cell adhesion, loss of the ECM, and constitutive activation of selected signal transduction pathways that promote cell growth and survival. Although mechanisms are important, attention also has to be paid to the target genes whose altered expression actually mediate the neoplastic phenotype. Other key avenues of work need to be explored. For example, it will be important to try to identify germline mutations in HBV-infected patients that are passed on to their children, resulting in the development of HCC in childhood. Clinical materials will also be important for the validation of new markers with diagnostic or prognostic potential. In this context, there is an urgent need to establish simple and low-cost tests based upon molecular changes that are hallmarks of HCC development. Identification of patients with early HCC will also significantly increase survival through its impact upon treatment. The discovery and validation of HCC markers may permit accurate staging of lesions, determine the proximity of such lesions to malignancy, and determine whether lesions with a particular genetic profile are still capable of remodeling through appropriate therapeutic intervention. The efficient reintroduction of the relevant tumor suppressors, or the inhibition of oncogene expression by siRNA, provide just some of the additional opportunities that will ultimately be useful in patient treatment. Together, these approaches will go far in reducing the very high morbidity and mortality associated with HCC." @default.
• W1995232559 created "2016-06-24" @default.
• W1995232559 creator A5010484062 @default.
• W1995232559 creator A5045947801 @default.
• W1995232559 creator A5047696180 @default.
• W1995232559 date "2004-04-01" @default.
• W1995232559 modified "2023-10-16" @default.
• W1995232559 title "Early molecular and genetic determinants of primary liver malignancy" @default.
• W1995232559 cites W1508483754 @default.
• W1995232559 cites W1796170190 @default.
• W1995232559 cites W1964699982 @default.
• W1995232559 cites W1966071985 @default.
• W1995232559 cites W1975702434 @default.
• W1995232559 cites W1978652110 @default.
• W1995232559 cites W1978713319 @default.
• W1995232559 cites W1980757890 @default.
• W1995232559 cites W1981089692 @default.
• W1995232559 cites W1984034083 @default.
• W1995232559 cites W1985598285 @default.
• W1995232559 cites W1987536971 @default.
• W1995232559 cites W1990563353 @default.
• W1995232559 cites W1993182122 @default.
• W1995232559 cites W1993785932 @default.
• W1995232559 cites W1996020231 @default.
• W1995232559 cites W1996884717 @default.
• W1995232559 cites W2003536893 @default.
• W1995232559 cites W2006499663 @default.
• W1995232559 cites W2012428824 @default.
• W1995232559 cites W2015227466 @default.
• W1995232559 cites W2015702695 @default.
• W1995232559 cites W2016576325 @default.
• W1995232559 cites W2019405416 @default.
• W1995232559 cites W2020209752 @default.
• W1995232559 cites W2022531340 @default.
• W1995232559 cites W2023358800 @default.
• W1995232559 cites W2030488757 @default.
• W1995232559 cites W2032352097 @default.
• W1995232559 cites W2032607892 @default.
• W1995232559 cites W2032781689 @default.
• W1995232559 cites W2034296773 @default.
• W1995232559 cites W2034975078 @default.
• W1995232559 cites W2035357005 @default.
• W1995232559 cites W2039690384 @default.
• W1995232559 cites W2041518108 @default.
• W1995232559 cites W2043499239 @default.
• W1995232559 cites W2050274505 @default.
• W1995232559 cites W2052788178 @default.
• W1995232559 cites W2056698743 @default.
• W1995232559 cites W2057676980 @default.
• W1995232559 cites W2058093105 @default.
• W1995232559 cites W2074137009 @default.
• W1995232559 cites W2074809432 @default.
• W1995232559 cites W2075793367 @default.
• W1995232559 cites W2076685716 @default.
• W1995232559 cites W2077717292 @default.
• W1995232559 cites W2078063877 @default.
• W1995232559 cites W2078110615 @default.
• W1995232559 cites W2078943507 @default.
• W1995232559 cites W2083771640 @default.
• W1995232559 cites W2085449895 @default.
• W1995232559 cites W2086493424 @default.
• W1995232559 cites W2094050302 @default.
• W1995232559 cites W2097587406 @default.
• W1995232559 cites W2103517190 @default.
• W1995232559 cites W2105912300 @default.
• W1995232559 cites W2107203451 @default.
• W1995232559 cites W2107404790 @default.
• W1995232559 cites W2112559353 @default.
• W1995232559 cites W2112781520 @default.
• W1995232559 cites W2115897923 @default.
• W1995232559 cites W2118231569 @default.
• W1995232559 cites W2120332259 @default.
• W1995232559 cites W2120434953 @default.
• W1995232559 cites W2129166145 @default.
• W1995232559 cites W2132708041 @default.
• W1995232559 cites W2146106047 @default.
• W1995232559 cites W2151530333 @default.
• W1995232559 cites W2153845396 @default.
• W1995232559 cites W2154110339 @default.
• W1995232559 cites W2154505792 @default.
• W1995232559 cites W2159670669 @default.
• W1995232559 cites W2170517917 @default.
• W1995232559 cites W2313449389 @default.
• W1995232559 cites W2314214777 @default.
• W1995232559 cites W2315900111 @default.
• W1995232559 cites W2326370166 @default.
• W1995232559 cites W2341084019 @default.
• W1995232559 cites W2346898172 @default.
• W1995232559 cites W4322378258 @default.
• W1995232559 doi "https://doi.org/10.1016/s0039-6109(03)00226-3" @default.
• W1995232559 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15062649" @default.
• W1995232559 hasPublicationYear "2004" @default.
• W1995232559 type Work @default.
• W1995232559 sameAs 1995232559 @default.
• W1995232559 citedByCount "49" @default.
• W1995232559 countsByYear W19952325592012 @default.
• W1995232559 countsByYear W19952325592013 @default.
• W1995232559 countsByYear W19952325592014 @default.

• next